|
Viewpoint
Health Care Policy and Law
Expansion of Civil Commitment for Substance Use Disorders—Not the Type of Commitment Our Patients Need
Michael A. Incze, MD, MSEd; Sirisha Narayana, MD; Aaron D. Fox, MD, MS
Original Investigation
Aging and Health
Respiratory Outbreak Mitigation With Point-of-Care Testing in Long-Term Care: A Randomized Clinical Trial
Christopher Kandel, MD, PhD; Daphne Oriotis, MSc; Heather L. Candon, MHM, CIC; et al.
Invited Commentary
Aging and Health
Point-of-Care Polymerase Chain Reaction Testing for Respiratory Viruses Among Nursing Home Residents to Reduce Hospital Transfers
Alison J. O’Donnell, MD, MPH; Robin L. P. Jump, MD, PhD
FROM JAMA THIS WEEK
Online Prescribing of GLP-1 Receptor Agonists
Ashwin K. Chetty, BS; Alissa S. Chen, MD, MPH, MHS; Joseph S. Ross, MD, MHS; et al
Alcohol-Related Liver Disease: A Review
Aleksander Krag, MD, PhD; Fredrik Åberg, MD, PhD; Jessica Mellinger, MD, MSc; et al
Surgical and Endoscopic Therapies for GERD
Sri Ganeshamurthy Thrumurthy, MBChB(Hons), LLM; Yuto Shimamura, MD, PhD; Jimmy Bok Yan So, MBChB, MPH
Comment & Response
Potential Biases in Assessment of Smallest Worthwhile Difference for Statin Therapy
Brett G. Fischer, MD
Editorial: Statins for Primary Prevention—The Gap Between Guidelines and Patient Preferences; Ilana B. Richman, MD, MHS; Anna Hung, PharmD, PhD; Timothy S. Anderson, MD, MAS
Potential Biases in Assessment of Smallest Worthwhile Difference for Statin Therapy—Reply
Yan Luo, MD, PhD; Hiroshi Kawakami, MD, MPH, PhD; Toshi A. Furukawa, MD, PhD
|